pubmed-article:14659815 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14659815 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:14659815 | lifeskim:mentions | umls-concept:C0020542 | lld:lifeskim |
pubmed-article:14659815 | lifeskim:mentions | umls-concept:C0036753 | lld:lifeskim |
pubmed-article:14659815 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:14659815 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:14659815 | pubmed:dateCreated | 2003-12-8 | lld:pubmed |
pubmed-article:14659815 | pubmed:abstractText | It has been reported that serotonin (5-HT) is involved in the development of pulmonary arterial hypertension (PAH) with pulmonary vascular remodeling. The purpose of the present study was to examine the role of a 5-HT2A receptor antagonist, sarpogrelate hydrochroride, in preventing or reversing monocrotaline (MCT)-induced PAH in rats. | lld:pubmed |
pubmed-article:14659815 | pubmed:language | eng | lld:pubmed |
pubmed-article:14659815 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14659815 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14659815 | pubmed:month | Dec | lld:pubmed |
pubmed-article:14659815 | pubmed:issn | 0008-6363 | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:TerasawaFumik... | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:OkumuraNobuoN | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:HongoMinoruM | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:KinoshitaOsam... | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:UshiyamaYoshi... | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:YazakiYoshika... | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:SakaiAkioA | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:HironakaEijiE | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:MawatariEiich... | lld:pubmed |
pubmed-article:14659815 | pubmed:author | pubmed-author:YamazakiAkieA | lld:pubmed |
pubmed-article:14659815 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14659815 | pubmed:day | 1 | lld:pubmed |
pubmed-article:14659815 | pubmed:volume | 60 | lld:pubmed |
pubmed-article:14659815 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14659815 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14659815 | pubmed:pagination | 692-9 | lld:pubmed |
pubmed-article:14659815 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:meshHeading | pubmed-meshheading:14659815... | lld:pubmed |
pubmed-article:14659815 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14659815 | pubmed:articleTitle | Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats. | lld:pubmed |
pubmed-article:14659815 | pubmed:affiliation | Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan. | lld:pubmed |
pubmed-article:14659815 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14659815 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14659815 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14659815 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14659815 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14659815 | lld:pubmed |